Merlin CP-GEP
Clinicopathologic gene-expression profile used to stratify sentinel-lymph-node positivity risk in early cutaneous melanoma.
- Developer
- SkylineDx
- Intended use
- Risk Stratification
- Cancer scope
- Cutaneous melanoma
- Specimen
- FFPE tumor tissue
- Molecular modality
- RNA expression
- Current version
- Current Merlin CP-GEP configuration (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 2 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.